Specialized Inspection of Medical Device Manufacturers Conducted in Jizhou District, Hengshui City, Hebei Province

Deep News
06/04

To reinforce the primary responsibility of medical device manufacturers for product quality and safety, regulate production and operational practices, and prevent and mitigate quality and safety risks, the Market Supervision Administration of Jizhou District in Hengshui City, Hebei Province, recently carried out a targeted inspection of medical device manufacturing enterprises. This initiative aims to comprehensively safeguard the quality and safety of medical devices within its jurisdiction.

Law enforcement personnel conducted in-depth inspections of key areas within the enterprises, including production workshops and storage warehouses. The focus was on critical stages such as raw material procurement and warehousing, personnel management, quality control during the production process, and final product inspection before leaving the factory. A thorough and meticulous review was conducted to accurately identify potential risks and hidden dangers in the production chain. For any issues discovered, on-site directives were issued requiring the enterprises to rectify them within a specified timeframe, resolutely preventing substandard medical devices from entering the market.

Simultaneously, officials held discussion sessions with enterprise management, providing face-to-face compliance guidance and addressing specific questions point-by-point. They worked to coordinate and resolve difficulties and bottlenecks encountered in the enterprises' production and operations, urging them to improve their management systems and standardize production processes. This effort is intended to firmly establish a solid foundation for safe medical device production.

Moving forward, the Jizhou District Market Supervision Administration will maintain a close watch on weak points in medical device supervision. It plans to enhance regular inspection routines and implement an irregular spot-check monitoring mechanism. The administration will continue to intensify regulatory enforcement, rigorously crack down on any illegal or non-compliant activities in medical device production, persistently standardize industry order, and protect public safety in the use of medical devices.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10